% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Huang:128631,
author = {Z. Huang$^*$ and D. Jones$^*$ and Y. Wu$^*$ and P.
Lichter$^*$ and M. Zapatka$^*$},
title = {conf{F}use: {H}igh-{C}onfidence {F}usion {G}ene {D}etection
across {T}umor {E}ntities.},
journal = {Frontiers in genetics},
volume = {8},
issn = {1664-8021},
address = {Lausanne},
publisher = {Frontiers Media},
reportid = {DKFZ-2017-04647},
pages = {137},
year = {2017},
abstract = {Background: Fusion genes play an important role in the
tumorigenesis of many cancers. Next-generation sequencing
(NGS) technologies have been successfully applied in fusion
gene detection for the last several years, and a number of
NGS-based tools have been developed for identifying fusion
genes during this period. Most fusion gene detection tools
based on RNA-seq data report a large number of candidates
(mostly false positives), making it hard to prioritize
candidates for experimental validation and further analysis.
Selection of reliable fusion genes for downstream analysis
becomes very important in cancer research. We therefore
developed confFuse, a scoring algorithm to reliably select
high-confidence fusion genes which are likely to be
biologically relevant. Results: confFuse takes multiple
parameters into account in order to assign each fusion
candidate a confidence score, of which score ≥8 indicates
high-confidence fusion gene predictions. These parameters
were manually curated based on our experience and on certain
structural motifs of fusion genes. Compared with alternative
tools, based on 96 published RNA-seq samples from different
tumor entities, our method can significantly reduce the
number of fusion candidates (301 high-confidence from 8,083
total predicted fusion genes) and keep high detection
accuracy (recovery rate $85.7\%).$ Validation of 18 novel,
high-confidence fusions detected in three breast tumor
samples resulted in a $100\%$ validation rate. Conclusions:
confFuse is a novel downstream filtering method that allows
selection of highly reliable fusion gene candidates for
further downstream analysis and experimental validations.
confFuse is available at
https://github.com/Zhiqin-HUANG/confFuse.},
cin = {B060 / B062},
ddc = {570},
cid = {I:(DE-He78)B060-20160331 / I:(DE-He78)B062-20160331},
pnm = {312 - Functional and structural genomics (POF3-312)},
pid = {G:(DE-HGF)POF3-312},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:29033976},
pmc = {pmc:PMC5627533},
doi = {10.3389/fgene.2017.00137},
url = {https://inrepo02.dkfz.de/record/128631},
}